BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8381154)

  • 1. Production and characterization of an Mls-1-specific monoclonal antibody.
    Mohan N; Mottershead D; Subramanyam M; Beutner U; Huber BT
    J Exp Med; 1993 Feb; 177(2):351-8. PubMed ID: 8381154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.
    Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H
    J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein.
    Acha-Orbea H; Scarpellino L; Shakhov AN; Held W; MacDonald HR
    J Exp Med; 1992 Dec; 176(6):1769-72. PubMed ID: 1334118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of Mls-1.
    Beutner U; Rudy C; Huber BT
    Int Rev Immunol; 1992; 8(4):279-88. PubMed ID: 1318934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
    Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
    J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7).
    Held W; Shakhov AN; Waanders G; Scarpellino L; Luethy R; Kraehenbuhl JP; MacDonald HR; Acha-Orbea H
    J Exp Med; 1992 Jun; 175(6):1623-33. PubMed ID: 1316932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7.
    Rudy CK; Kraus E; Palmer E; Huber BT
    J Exp Med; 1992 Jun; 175(6):1613-21. PubMed ID: 1316931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7.
    Beutner U; Frankel WN; Cote MS; Coffin JM; Huber BT
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5432-6. PubMed ID: 1319061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superantigens of mouse mammary tumor virus.
    Acha-Orbea H; MacDonald HR
    Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus.
    Waanders GA; Shakhov AN; Held W; Karapetian O; Acha-Orbea H; MacDonald HR
    J Exp Med; 1993 May; 177(5):1359-66. PubMed ID: 8386743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
    Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
    J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
    Foo-Phillips M; Kozak CA; Principato MA; Abe R
    J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor.
    Woodland DL; Smith HP; Surman S; Le P; Wen R; Blackman MA
    J Exp Med; 1993 Feb; 177(2):433-42. PubMed ID: 8381156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
    Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP
    J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
    J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens.
    Pullen AM; Choi Y; Kushnir E; Kappler J; Marrack P
    J Exp Med; 1992 Jan; 175(1):41-7. PubMed ID: 1309854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.